Article Text

Download PDFPDF
Ampicillin in the treatment of brucellosis: A controlled therapeutic trial
  1. D. G. McDevitt
  1. Department of Therapeutics and Pharmacology, Queen's University, Belfast


    McDevitt, D. G. (1970).Brit. J. industr. Med.,27, 67-71. Ampicillin in the treatment of brucellosis: A controlled therapeutic trial. A controlled therapeutic trial has been carried out with ampicillian in the treatment of brucellosis. Sixty-eight people, veterinary surgeons or their unqualified assistants, with serological evidence of brucella antibodies measured by the anti-human globulin (Coombs) test and the complement-fixation test, some of whom had symptoms consistent with a diagnosis of brucellosis, were treated in two random groups. One group was given ampicillin, 1 g. four times a day for 28 days; the other took a placebo in identical capsules for the same period. The response to treatment was gauged by subjective improvement in symptoms four weeks after its completion and by serological improvement after four months. Fifty-four people completed the trial.

    There was no evidence that ampicillin was any more effective than the placebo in treatment, either symptomatically or serologically, but 25% of the people in both treatment groups reported subjective symptomatic improvement. It is suggested, therefore, that subjective improvement alone is an inadequate criterion for assessing response to treatment in culturally unproven brucellosis, and that, because of this, current conventional therapies may require critical revaluation. Similarly, a subjective therapeutic response cannot be relied upon for diagnostic confirmation in a patient in whom the diagnosis is uncertain.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.